Decade-long WT1-specific CTLs induced by WT1 peptide vaccination
CONCLUSION: The WT1 peptide vaccine induced an immune response that persists for more than 10 years, even after cessation of vaccination in the CML patient.PMID:38427208 | DOI:10.1007/s12185-024-03723-1
Source: International Journal of Hematology - Category: Hematology Authors: Tatsuya Suwabe Yasuhiko Shibasaki Suguru Tamura Takayuki Katagiri Kyoko Fuse Tori Ida-Kurasaki Takashi Ushiki Hirohito Sone Miwako Narita Masayoshi Masuko Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Gleevec | Hematology | Study | Vaccines | Wilm's Tumor